Joined November 2020
- Tweets 22
- Following 61
- Followers 49
- Likes 22
3 Photos and videos
Heather Poad retweeted
13 Dec 2022
PhD opportunity with me at @UoL_Biostats, @Richard_D_Riley, Anne Thomas and Samantha Wilkinson at Roche. Model-driven and data-driven solutions for regulatory and HTA decision-making to address emerging challenges in drug development in cancer. Apply here: more.bham.ac.uk/mrc-aim/phd-…
10
15
Heather Poad retweeted
8 Nov 2022
2
7
9 Nov 2022
Lovely to watch @SBujkiewicz in action at the last breakout session of #ISPOREurope 2022: sharing of information in evidence synthesis to strengthen HTA decisions. @UoL_Biostats
3
Heather Poad retweeted
9 Nov 2022
More @NIHRresearch at #ISPOREurope by Jan Singh from his NIHR doctoral fellowship @UoL_Biostats
1
5
Heather Poad retweeted
8 Nov 2022
This is us! BayesHTA @UoL_Biostats
Nice to be part of #ISPOREurope
@HeatherPoad @WheatonLorna and Jan Singh
1
7
Heather Poad retweeted
3 Nov 2022
@HeatherPoad MSR21: Exploration of the Impact of the Treatment Mechanism of Action on the Surrogate Relationship Between Progression Free Survival and Overall Survival in Metastatic Colorectal Cancer Monday Poster Session 1; 10:00-13:15
4
1
1
7 Nov 2022
Presenting my poster: Exploration of the impact of the treatment mechanism of action on the surrogate relationship between Progression free survival and overall survival in metastatic colorectal cancer, at #ISPOREurope today!
2
2
16
Heather Poad retweeted
3 Nov 2022
My team and I from @UoL_Biostats are presenting at #ISPOREurope
7 presentations on evidence synthesis: methods and applications – details to follow in the thread
3
3
10
4 Nov 2022
Thanks @SBujkiewicz for sharing my paper, beat me to tweeting about it! This is my first, first author paper, and the first paper published from my PhD @Cancers_MDPI @UoL_Biostats
2 Nov 2022
New paper - congratulations @HeatherPoad on the first paper from your PhD: The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status mdpi.com/1921032 #mdpicancers via @Cancers_MDPI
1
1
23 Jun 2021
Attending #HTAi2021VirtualAM this week. Last day already! Proud to have my poster "Validity of Surrogate Endpoints in Subgroups of Patients with Advancd Colorectal Cancer Defined by the KRAS Biomarker Status" co-authors @SBujkiewicz @michaelsweeting up in the poster gallery.
1
3
12
Heather Poad retweeted
21 Jan 2021
Final year UK med student here. Going public with some experiences of a compulsory online exam. Summary: students threatened with disqualification from becoming doctors (in a pandemic) due to problems with online exams (incl. some being forced to urinate in their seats)
123
1,091
1,954
20 Jan 2021
I signed the petition for 100% responsibility in chocolate supply chains. MAKE SOME NOISE with me: tonyschocolonely.com/petitio…
Heather Poad retweeted
2 Jan 2021
This video from @educationgovuk uses the word "SAFE" six times. That is six lots of FALSE REASSURANCE. Negative results from a lateral flow test DO NOT make you safe. Please please please Government, get your heads round this FAST.
2 Jan 2021
Students and staff at @NCLSixthForm have been taking part in the recent coronavirus testing pilot schemes.
They explain how the tests work and how simple they are to do.
22
103
222
Heather Poad retweeted
2 Jan 2021
I’ve given half my life to medicine.
And medicine wouldn’t give my husband a chest x-ray.
Some kids stole a truck yesterday.
And they almost stole my husband’s life alongside it.
(1)
1,301
8,201
35,166
Heather Poad retweeted
27 Dec 2020
Have you heard of #BladderCancer? It's time you did - it's the 5th most common cancer in Europe, and it affects all ages 🏵️ Share this post and help spread awareness 🏵️
Be #BladderCancerAware #5thmostcommon
33
40
Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study ascopubs.org/doi/abs/10.1200…
5
78
191
Heather Poad retweeted
4 Dec 2020
If a hospital was cutting corners in their medical care, we would be appalled & immediate action taken to stop this. Yet when science & researchers cut corners in methodology we might frown and highlight the bad practice, but rarely is action taken to prevent it happening again.
5
5
32
16 Nov 2020
Attending my first conference #ISPOREurope and presenting a poster with a small part of my PhD work! @ISPORorg @SBujkiewicz @michaelsweeting
2
3
18